Petra Budde

885 total citations
36 papers, 648 citations indexed

About

Petra Budde is a scholar working on Radiology, Nuclear Medicine and Imaging, Rheumatology and Immunology. According to data from OpenAlex, Petra Budde has authored 36 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Rheumatology and 12 papers in Immunology. Recurrent topics in Petra Budde's work include Monoclonal and Polyclonal Antibodies Research (20 papers), Systemic Lupus Erythematosus Research (13 papers) and Advanced Proteomics Techniques and Applications (6 papers). Petra Budde is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (20 papers), Systemic Lupus Erythematosus Research (13 papers) and Advanced Proteomics Techniques and Applications (6 papers). Petra Budde collaborates with scholars based in Germany, United States and Sweden. Petra Budde's co-authors include J Frey, Katja Tœnsing, Eberhard Neumann, Sergej Kakorin, Jürgen Frey, Harald Tammen, Peter Schulz‐Knappe, Hans‐Dieter Zucht, Rüdiger Hess and Susheela Tridandapani and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Petra Budde

33 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra Budde Germany 14 260 168 160 105 97 36 648
Gowri Rangaswamy Gunassekaran South Korea 13 517 2.0× 348 2.1× 59 0.4× 33 0.3× 198 2.0× 14 880
Luca Lavra Italy 13 362 1.4× 342 2.0× 17 0.1× 14 0.1× 108 1.1× 20 886
Mai Zhang China 13 521 2.0× 527 3.1× 156 1.0× 63 0.6× 9 0.1× 29 1.1k
Helena Yusuf‐Makagiansar United States 11 545 2.1× 192 1.1× 238 1.5× 53 0.5× 104 1.1× 13 885
Alex D. Colella Australia 15 170 0.7× 105 0.6× 58 0.4× 12 0.1× 17 0.2× 26 567
Sophie Conchon France 20 624 2.4× 291 1.7× 57 0.4× 48 0.5× 36 0.4× 39 1.1k
Arantxa Acera Spain 19 234 0.9× 43 0.3× 827 5.2× 12 0.1× 51 0.5× 54 1.6k
Li‐Ping Liu China 14 324 1.2× 240 1.4× 47 0.3× 9 0.1× 35 0.4× 39 864
Grace Chan United States 18 361 1.4× 161 1.0× 212 1.3× 23 0.2× 19 0.2× 45 736
Beatriz García Spain 19 468 1.8× 51 0.3× 61 0.4× 18 0.2× 24 0.2× 43 920

Countries citing papers authored by Petra Budde

Since Specialization
Citations

This map shows the geographic impact of Petra Budde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Budde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Budde more than expected).

Fields of papers citing papers by Petra Budde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Budde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Budde. The network helps show where Petra Budde may publish in the future.

Co-authorship network of co-authors of Petra Budde

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Budde. A scholar is included among the top collaborators of Petra Budde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Budde. Petra Budde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hajjar, Joud, Bettzy Stephen, Serdar A. Gurses, et al.. (2025). Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors. ESMO Open. 10(8). 105518–105518. 1 indexed citations
2.
Budde, Petra, Thomas Dörner, Diana Ernst, et al.. (2025). Identification of novel autoantibodies in Sjögren’s disease. Frontiers in Immunology. 16. 1524940–1524940.
3.
Wu, Yin, Nicholas Geraci, Petra Budde, et al.. (2024). TLR7/8 Activation in Immune Cells and Muscle by RNA‐Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis. Arthritis & Rheumatology. 77(2). 190–201. 6 indexed citations
4.
Ravi, Praful, Dory Freeman, Jonathan Thomas, et al.. (2024). Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer. Journal for ImmunoTherapy of Cancer. 12(2). e008215–e008215. 2 indexed citations
5.
Liu, Yunxian, Joseph E. Ebinger, Petra Budde, et al.. (2021). Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection. Journal of Translational Medicine. 19(1). 524–524. 42 indexed citations
6.
Vordenbäumen, Stefan, Ralph Brinks, Angelika Lueking, et al.. (2020). Profiling of IgG antibodies targeting unmodified and corresponding citrullinated autoantigens in a multicenter national cohort of early arthritis in Germany. Arthritis Research & Therapy. 22(1). 167–167. 4 indexed citations
7.
Hassel, Jessica C., Hans‐Dieter Zucht, Joanna Mangana, et al.. (2020). Autoantibodies as predictors for survival and immune-related adverse events in checkpoint inhibition therapy of metastasized melanoma.. Journal of Clinical Oncology. 38(15_suppl). 10011–10011. 5 indexed citations
8.
Ling, Stephanie F, Nisha Nair, Suzanne Verstappen, et al.. (2019). Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients. The Pharmacogenomics Journal. 20(3). 516–523. 9 indexed citations
9.
Ling, Stephanie F, Nisha Nair, Darren Plant, et al.. (2019). SAT0098 ANTIBODIES AGAINST CITRULLINATED ANTIGENS ARE ASSOCIATED WITH TREATMENT RESPONSE IN ACPA-NEGATIVE RHEUMATOID ARTHRITIS PATIENTS. Annals of the Rheumatic Diseases. 78. 1115–1115.
10.
Vordenbäumen, Stefan, Ralph Brinks, Rebecca Fischer‐Betz, et al.. (2017). High diagnostic accuracy of histone H4-IgG autoantibodies in systemic lupus erythematosus. Lara D. Veeken. 57(3). 533–537. 10 indexed citations
11.
Vordenbäumen, Stefan, Angelika Lueking, Petra Budde, et al.. (2016). Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis. Arthritis Research & Therapy. 18(1). 235–235. 13 indexed citations
12.
Jost, Marco, Jens Lamerz, Harald Tammen, et al.. (2008). In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma. Biochemical Pharmacology. 77(2). 228–237. 24 indexed citations
13.
Tammen, Harald, Hans‐Dieter Zucht, & Petra Budde. (2007). Oncopeptidomics – A commentary on opportunities and limitations. Cancer Letters. 249(1). 80–86. 11 indexed citations
14.
Traub, Frank, Marco Jost, Rüdiger Hess, et al.. (2006). Peptidomic analysis of breast cancer reveals a putative surrogate marker for estrogen receptor-negative carcinomas. Laboratory Investigation. 86(3). 246–253. 29 indexed citations
15.
Jost, Marco, Petra Budde, Harald Tammen, et al.. (2005). The Concept of Functional Peptidomics for the Discovery of Bioactive Peptides in Cell Culture Models. Combinatorial Chemistry & High Throughput Screening. 8(8). 767–773. 13 indexed citations
16.
Tammen, Harald, Rüdiger Hess, Imke Schulte, et al.. (2005). Prerequisites for Peptidomic Analysis of Blood Samples: II. Analysis of Human Plasma after Oral Glucose Challenge - A Proof of Concept. Combinatorial Chemistry & High Throughput Screening. 8(8). 735–741. 15 indexed citations
17.
Budde, Petra, Imke Schulte, Susanne Neitz, et al.. (2005). Peptidomics Biomarker Discovery in Mouse Models of Obesity and Type 2 Diabetes. Combinatorial Chemistry & High Throughput Screening. 8(8). 775–781. 20 indexed citations
18.
Engelke, Michael, Petra Budde, Christof Zitt, et al.. (2002). Structural domains required for channel function of the mouse transient receptor potential protein homologue TRP1β. FEBS Letters. 523(1-3). 193–199. 39 indexed citations
19.
Rathke‐Hartlieb, Silvia, Petra Budde, Stefan Ewert, et al.. (2000). Elevated expression of membrane type 1 metalloproteinase (MT1‐MMP) in reactive astrocytes following neurodegeneration in mouse central nervous system. FEBS Letters. 481(3). 227–234. 31 indexed citations
20.
Neumann, Eberhard, Katja Tœnsing, Sergej Kakorin, Petra Budde, & J Frey. (1998). Mechanism of Electroporative Dye Uptake by Mouse B Cells. Biophysical Journal. 74(1). 98–108. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gowri Rangaswamy Gunassekaran Breakdown of academic impact, for papers by Luca Lavra Breakdown of academic impact, for papers by Mai Zhang Breakdown of academic impact, for papers by Helena Yusuf‐Makagiansar Breakdown of academic impact, for papers by Alex D. Colella Breakdown of academic impact, for papers by Sophie Conchon Breakdown of academic impact, for papers by Arantxa Acera Breakdown of academic impact, for papers by Li‐Ping Liu Breakdown of academic impact, for papers by Grace Chan Breakdown of academic impact, for papers by Beatriz García
Rankless by CCL
2026